Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

Phase 2 N=30 IVIG (Gamunex-C) Treatment Study for POTS Subjects

Postural Tachycardia Syndrome
Primary: Change in Symptoms Measured by Change in COMPASS-31 Score (After Initial Treatment Phase) — -5.5; -10.6 score on a scale — p=0.629
University of Texas Southwestern Medical Center Results Sep 2024 7.4% serious AE View details

Phase 2 N=94 GM1 Ganglioside Effects on Parkinson's Disease

Parkinson Disease
Primary: Change in Unified Parkinson's Disease Rating Scale (UPDRS) (Part III) Motor Score From Baseline to Week 24 Assessed Off Medication. — -3.57; 1.85 Scores on a scale…
Thomas Jefferson University Results Aug 2012 3.2% serious AE View details

Phase 2 N=89 ATG-GCSF in New Onset Type 1 Diabetes

Diabetes Mellitus, Type 1
Primary: Change in Area Under the Stimulated C-peptide Curve From Baseline to 12 Months. — 0.528; 0.646; 0.406 nmol/L
National Institute of Diabetes and Digestive and… Results Mar 2020 73.0% serious AE View details

Phase 2 N=49 Study of AG10 in Amyloid Cardiomyopathy

Familial ATTR-CM (ATTRm-CM, or FAC) · Wild-type ATTR-CM (ATTRwt-CM)
Primary: Change in Diastolic Blood Pressure — -3.1; -3.3; -4.3; -2.6 mm Hg
Eidos Therapeutics, a BridgeBio company Results Nov 2022 6.1% serious AE View details